Valuation: Photocure ASA

Market Cap 1.35B 144M 128M 118M 107M 200M 13.61B 205M 1.41B 557M 7.12B 538M 527M 22.54B P/E 2026 *
17.7x
P/E 2027 * 64.2x
Enterprise Value 1.18B 126M 112M 103M 93.75M 175M 11.9B 179M 1.24B 487M 6.22B 471M 461M 19.71B EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.79x
Free-Float
95.71%
Yield 2026 *
-
Yield 2027 * -
1 day+0.30%
1 week+1.21%
Current month-0.40%
1 month-3.09%
3 months-13.17%
6 months-33.82%
Current year-29.83%
1 week 48.9
Extreme 48.9
50.5
1 month 47.1
Extreme 47.1
53.1
Current year 46.25
Extreme 46.25
79.8
1 year 46.25
Extreme 46.25
79.8
3 years 46.25
Extreme 46.25
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 31/10/2018
Chief Tech/Sci/R&D Officer - 31/07/2021
Human Resources Officer - 31/01/2021
Director TitleAgeSince
Director/Board Member - 31/12/2021
Chairman - 26/09/2023
Director/Board Member - 22/05/2024
Date Insider Type Main position Quantity % Market Cap. Importance
02/04/25 BuyCompany 11,355 0.0419%
02/04/25 BuyCompany 8,997 0.0332%
31/03/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.30%+1.21%-5.11%-9.24% 143M
+3.49%+8.54%+59.89%+117.27% 1,106B
+2.19%-1.66%+34.23%+70.27% 612B
+2.26%+2.83%+25.92%+98.65% 500B
+2.58%+8.31%+37.43%+63.51% 367B
+3.25%+1.96%+74.90%+47.67% 354B
+1.85%+5.45%+21.38%+49.26% 286B
+1.76%+4.92%+0.48%+20.31% 256B
+3.29%+5.12%+46.90%+56.43% 230B
+2.25%+4.04%+27.44%+99.53% 190B
Average +0.79%+2.01%+32.35%+61.37% 390.03B
Weighted average by Cap. +0.44%+2.30%+41.69%+80.32%

Financials

2026 *2027 *
Net sales 658M 70.08M 62.33M 57.69M 52.33M 97.76M 6.64B 99.92M 691M 272M 3.47B 263M 257M 11B 666M 70.93M 63.09M 58.39M 52.96M 98.95M 6.72B 101M 699M 275M 3.52B 266M 261M 11.14B
Net income 76.33M 8.13M 7.23M 6.69M 6.07M 11.34M 770M 11.59M 80.08M 31.54M 403M 30.48M 29.85M 1.28B 21M 2.24M 1.99M 1.84M 1.67M 3.12M 212M 3.19M 22.03M 8.68M 111M 8.39M 8.21M 351M
Net Debt -169M -17.99M -16M -14.81M -13.43M -25.1M -1.71B -25.65M -177M -69.82M -892M -67.48M -66.08M -2.82B -157M -16.71M -14.86M -13.76M -12.48M -23.31M -1.58B -23.83M -165M -64.87M -828M -62.69M -61.39M -2.62B
Projected Income Statement - Annual - Photocure ASA
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
20/10/26 NOK 50.10 +0.30% 21,186
19/10/26 NOK 49.95 +0.40% 30,984
16/10/26 NOK 49.75 +1.02% 29,517
15/10/26 NOK 49.25 -0.71% 23,611
14/10/26 NOK 49.60 +1.12% 21,880
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Photocure ASA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
50.10NOK
Average target price
79.67NOK
Spread / Average Target
+59.02%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Photocure ASA